Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,523 | -28,340 | -29,883 | -23,485 | -11,883 |
| Depreciation Amortization | -2,523 | -62 | 1,272 | 1,018 | 404 |
| Accounts payable and accrued liabilities | -292 | -501 | -19 | 594 | 386 |
| Other Working Capital | -363 | 13,414 | 14,651 | 2,842 | 304 |
| Other Operating Activity | 790 | 1,619 | 2,062 | 3,194 | 2,798 |
| Operating Cash Flow | $-20,911 | $-13,870 | $-11,917 | $-15,837 | $-7,991 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,695 | 12,742 | -26,350 | N/A | N/A |
| PPE Investments | -287 | -2,560 | -1,335 | -2,615 | -763 |
| Purchase Sale Intangibles | -156 | -710 | -417 | -1,951 | -318 |
| Other Investing Activity | -156 | -710 | -417 | -1,951 | -318 |
| Investing Cash Flow | $-24,138 | $9,472 | $-28,102 | $-4,566 | $-1,081 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,571 | 1,101 | 371 | 50,705 | 184 |
| Common Stock Repurchased | N/A | N/A | -4 | -8 | N/A |
| Other Financing Activity | 366 | 58 | 248 | 79 | 31,805 |
| Financing Cash Flow | $43,937 | $1,159 | $615 | $50,776 | $31,989 |
| Beginning Cash Position | 13,189 | 17,439 | 56,843 | 26,470 | 3,553 |
| End Cash Position | 12,077 | 14,200 | 17,439 | 56,843 | 26,470 |
| Net Cash Flow | $-1,112 | $-3,239 | $-39,404 | $30,373 | $22,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,911 | -13,870 | -11,917 | -15,837 | -7,991 |
| Capital Expenditure | -287 | -2,560 | -1,335 | -2,615 | -763 |
| Free Cash Flow | -21,198 | -16,430 | -13,252 | -18,452 | -8,754 |